default author photo

Jin Seok Ahn

Sungkyunkwan University - Division of Hematology-Oncology

81, Irwon- Ro

Gangnam-gu

Seoul, 135-710

Korea, Republic of (South Korea)

SCHOLARLY PAPERS

3

DOWNLOADS

218

TOTAL CITATIONS

0

Scholarly Papers (3)

1.

Randomised Phase II Study of Palbociclib Plus Exemestane with GnRH Agonist Versus Capecitabine in Premenopausal Women with Hormone Receptor-Positive HER2-Negative Metastatic Breast Cancer

Number of pages: 90 Posted: 10 Jul 2019
Sungkyunkwan University - Division of Hematology-Oncology, Seoul National University - Department of Internal Medicine, Yonsei University - Department of Internal Medicine, University of Ulsan - Department of Oncology, Ajou University - School of Medicine, National Cancer Center, Korea, Seoul National University - Department of Internal Medicine, Ewha Womans University, Gachon University - Department of Internal Medicine, Inha University - Department of Internal Medicine, Chung-Ang University, College of Medicine, Department of Internal Medicine, Sungkyunkwan University - Division of Hematology-Oncology, Yonsei University - Department of Internal Medicine, University of Ulsan - Department of Hematology and Oncology, Sungkyunkwan University - Division of Hematology-Oncology, Seoul National University - Department of Internal Medicine, Yonsei University - Yonsei Cancer Center, University of Ulsan - Department of Oncology, Sungkyunkwan University - Division of Hematology-Oncology, Sungkyunkwan University - Division of Hematology-Oncology and Seoul National University - Department of Internal Medicine
Downloads 118 (604,538)

Abstract:

Loading...

HR-positive, HER2-negative metastatic breast cancer; premenopausal women; palbociclib, exemestance, capecitabine

2.

Comprehensive Genomic Analysis of Non-Small Cell Lung Cancer for Predicting Treatment Response to Immunotherapy

Number of pages: 40 Posted: 17 Jun 2019
Sungkyunkwan University - School of Medicine, Seoul National University Cancer Research Institute, Sungkyunkwan University - School of Medicine, Sungkyunkwan University - School of Medicine, Sungkyunkwan University - Samsung Medical Center, Sungkyunkwan University - Division of Hematology-Oncology, Sungkyunkwan University - Division of Hematology-Oncology, Sungkyunkwan University - Division of Hematology-Oncology, Seoul National University Cancer Research Institute, Seoul National University - Seoul National University Boramae Hospital, Sungkyunkwan University - Division of Hematology-Oncology, Sungkyunkwan University - School of Medicine and Sungkyunkwan University - Division of Hematology-Oncology
Downloads 67 (899,324)

Abstract:

Loading...

Non-small cell lung cancer; tumor mutation burden, immunotherapy, Homologous recombination deficiency, STING pathway

3.

Temporal Pattern of Chronic Disease Incidence After Breast Cancer: A Nationwide Population-Based Cohort Study

THELANCETONCOLOGY-D-20-02253
Number of pages: 35 Posted: 11 Nov 2020
Sungkyunkwan University - Department of Clinical Research Design and Evaluation, Sungkyunkwan University - Department of Digital Health, Johns Hopkins University - Departments of Epidemiology and Medicine, Johns Hopkins University - Departments of Epidemiology and Medicine, Department of Clinical Research Design and Evaluation, SAIHST, Sungkyunkwan University, Medical Informatics and Health Technology (MIT), Department of Health Care Management, College of Social Science, Gachon University, Department of Big Data, National Health Insurance Service, Sungkyunkwan University - Division of Hematology-Oncology, Sungkyunkwan University - Division of Hematology-Oncology, Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Department of Clinical Research Design and Evaluation, SAIHST, Sungkyunkwan University, Johns Hopkins University - Department of Epidemiology and Sungkyunkwan University - Department of Clinical Research Design and Evaluation
Downloads 33 (1,277,121)

Abstract:

Loading...